Clinical Trial Update: Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD) [Phase 2]

View source ↗

Summary

Phase 2 trial update on sequential treatment for CD20-positive post-transplant lymphoproliferative disorder, with the study status listed as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-transplant Lymphoproliferative Disorder

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Post-transplantation Lymphoproliferative Disorder | Phase 2 | Status: TERMINATED